Therefore, we used flow cytometry to sort two cell fractions from a late (passage 10) blastemal Wilms' tumor patient-derived xenograft (WT-PDX): NCAM+/ALDH1+ and NCAM+/ALDH1−. The gene discussed is ALDH1A1; the disease is Wilms tumor.